Bayer-Schering Pharmaceuticals: A $20B Merger?
Filed in archive Corporate and Industrial News on April 13, 2006
Yes, that's right. If Schering accepts the bid, two of Germany's biggest pharmaceutical companies would merge and operate under one name. Bayer AG offered $20.01 billion, equivalent to $104.28 per share, making the other contender, Merck KGaA, abandon the takeover bidding. The impacts of this potential merger?
The planned merger of Schering AG and the Bayer pharmaceuticals division will create a new heavyweight of international standing in pharmaceutical specialty products.
It is also expected to result in the loss of some 6,000 jobs from the combined work force of about 60,000.
The combined company is to be named Bayer-Schering Pharmaceuticals and have its headquarters in Berlin.
It is also expected to result in the loss of some 6,000 jobs from the combined work force of about 60,000.
The combined company is to be named Bayer-Schering Pharmaceuticals and have its headquarters in Berlin.
Tags: merger pharmaceutical biotech pharmaceuticals schering schering+pharmaceuticals bayer+schering pharm
Vote for Bayer-Schering Pharmaceuticals: A $20B Merger?:
|
Rating: 9.33 out of 3 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells